Symfo, a provider of electronic patient reported outcome (ePRO) solutions for clinical trials, announced that its SymPhone eDiary is now equipped for wireless or landline data transfers. The SymPhone now offers sponsors the flexible solution of letting patients send data either through wireless (GSM) or landline (IDR) technology, whichever is the most convenient. “By adding the dual interface for data transmissions, we can give our customers absolute peace of mind with regards to how patients send their data,” said Serge Bodart, Symfo’s CEO. “This new feature combines the best of both worlds: allowing patients without access to landlines to go wireless, and allowing patients without GSM coverage to utilize a landline to send their information.” Symfo will be showcasing the SymPhone diary at the DIA 43rd Annual Meeting in Atlanta at Booth no. 1708.

The results of a recent survey conducted by ePharmaSolutions, a provider of technology-enhanced clinical services, demonstrated the relationships of clinical sites with pharmaceutical companies, their motivations for conducting research, and the technology solutions for conducting trials efficiently, and so on. The survey was conducted including over 1100 sites in more than 55 countries. For more details on this survey, please contact ePharmaSolutions team or visit them at the 43rd Annual DIA Meeting in Atlanta at Booth 1216.

etrials, a clinical trial technology suite, recently announced its plans to formally launch its EDC 2.0 solution during the 43rd DIA meeting in Atlanta this week. The company’s EDC solution enables a quick-start study development and deployment, along with enhanced reporting and analytics capabilities through user-friendly, adaptable design tools. “This event assembles an array of expert professionals, regulatory specialists and renowned researchers from the drug development industry, and we are thrilled to offer them EDC 2.0,” said Rick Piazza, vice president of product strategy at etrials.

Phase Forward, a clinical trial technology suite, will be hosting an analyst day on Tuesday, June 19th at DIA in Atlanta, Georgia. The company will discuss the launch of its new Central Designer application targeted at the EDC market, and provide demos of this new application, as well as the company’s InForm EDC product and CTSD clinical trials safety signal detection software. The presentation will be webcast live and available by visiting the investor relations section of the website.

Have a news release? Send it to .(JavaScript must be enabled to view this email address). Need to deliver your marketing message to the most focused, dedicated online readership in the clinical trial community? Talk to .(JavaScript must be enabled to view this email address) about advertising on ClinPage: (857) 233-0168 x103. He’s down at DIA this week.